Abstract
Lung transplantation is a therapeutic option for patients with end-stage lung disease for which no other treatments exist. Since 2012, the number of new candidates added to the wait list and the number of lung transplantations performed in the United States has increased (1). Despite an increase in the number of lung donor counts by 13.9% from 2015–2016, the overall mortality rate for candidates listed for lung transplant is 17.2 per 100 wait-list years (1,2).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
